• Fri, September 20, 2024
Oren Livnat Maintained (zvra) at Strong Buy with Increased Target to $20 on, Sep 20th, 2024
Oren Livnat of HC Wainwright & Co., Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $18 to $20 on, Sep 20th, 2024.
Oren has made no other calls on ZVRA in the last 4 months.
There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024
Like: 👍
